R&D Systems™ Recombinant Human CD19 Fc Chimera Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Supplier:  R&D Systems™ 9269CD050

Catalog No. 92-69C-D050

Description

The Recombinant Human CD19 Fc Chimera Protein is derived from CHO. The Recombinant Human CD19 Fc Chimera Protein has been validated for the following applications: Bioactivity.

Order Info

The product is shipped at ambient temperature.

Specifications

• Accession Number: P15391
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS and NaCl
• Molecular Weight (g/mol): 77 to 92 kDa, reducing conditions
• Quantity: 50μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of protein by LAL method
• Product Type: Recombinant protein
• Species: Human
• Protein Tag: No

• For Use With (Application): Bioactivity
• Gene ID (Entrez): 930
• Name: B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19, CD19 antigen, CD19 molecule, CVID3, Differentiation antigen CD19, Leu-12, MGC12802, T-cell surface antigen Leu-12
• Source: Chinese Hamster Ovary cell line,CHO-derived human CD19 protein, (N-terminus) Human CD19 (Glu21-Lys291) Accession &Num; P15391 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Regulatory Status: RUO
• Biological Activity: 4 to 20μg/mL (ED 50)
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.

For Research Use Only